(4aR,8aR)-Ethyl 7-oxooctahydro-2H-pyrano[3,2-c]pyridine-4a-carboxylate, 95%, 250mg

6-Methoxy-1-indanone, 98.0%, 25g

(R)-METHYL 3-AMINO-3-(3-BROMOPHENYL)PROPANOATE HCL, 95.0%, 1g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 20000 ml, 315 mm, 1 Piece

Ethyl 3,4,5-trimethoxybenzoylacetate, 95.0%, 100mg

METHYL 3-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXYLATE, 95.0%, 5g

Poloxamer 188, 250 g

2-[3-(2-hydroxyethyl)-4-oxo-3,4-dihydrophthalazin-1-yl]acetic acid, 98%, 250mg

4-Bromo-2,3-dimethylpyridine, 95.0%, 1g

1,2-Difluoro-4-(methylsulfonyl)benzene, 97.0%, 10g

(4-(Dimethylamino)pyridin-2-yl)methanol, 95%, 250mg

2-Chloro-3-fluoronitrobenzene, 98.0%, 10g

Butanoic acid,(2,2-dimethyl-1-oxopropoxy)methyl ester, 95%, 1g